Owner Novartis AG

Inventors Leppert, David; Wallstroem, Erik; Nuesslein-Hildesheim, Barbara

Agent Davies Collison Cave

Pub. Number AU-A-2009284128

PCT Pub. Number WO2010/020610

Priority 08162517.0 18.08.08 EP

Filing date 17 August 2009

Wipo publication date 25 February 2010

A61K 31/397 (2006.01) - having four-membered rings, e.g. azetidine

A61K 31/16 (2006.01) - Amides, e.g. hydroxamic acids

A61K 31/195 (2006.01)

A61K 31/34 (2006.01) - having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide

A61K 31/401 (2006.01) - Proline

A61K 31/417 (2006.01)

A61K 31/42 (2006.01) - Oxazoles

A61K 31/436 (2006.01)

A61K 31/452 (2006.01) - Piperidinium derivatives

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61K 31/52 (2006.01)

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

A61K 38/13 (2006.01) Medicinal preparations containing peptides

A61P 25/00 (2006.01) Drugs for disorders of the nervous system